Evidence-Based cfDNA Diagnostics to Help Increase Pet Healthspan
DeepScan's cfDNA diagnostics help veterinarians detect and monitor disease earlier, supporting better decisions and longer pet healthspan.
Trusted by Leaders in Veterinary Research and Clinical Practice
“Our profession has been searching for an ease of use, affordable and accurate blood test that can serve as an aid in cancer diagnosis and a tool for treatment monitoring. CFD has the potential to fundamentally improve how cancer treatments are planned in the future, providing better outcomes for our patients and clarity for their families.”
Zachary M. Wright
Medical Director,
VCA Dallas Animal Specialty Hospital
April 15, 2026
Rethinking the Dog Bowl: What Emerging Science Says About Food, Timing, and Longevity
February 2, 2026
Bernese Mountain Dog Lifespan: Why This Gentle Giant Lives Only 6-8 Years
January 26, 2026
DeepScan at VMX 2026
January 22, 2026
Labrador Retriever Cancer Risk: What Every Owner Should Know
January 15, 2026
Why Do Boxers Get Cancer? Understanding the Breed with the Highest Cancer Rate
December 8, 2025
Post-Op Monitoring: The 'Clean Slate' Protocol
December 1, 2025
IMHA, NETs, and the Clotting Risk: The DNA Connection
November 24, 2025
Trauma and Ischemia: Quantifying the 'Hit'
November 17, 2025
The 'Cooler' Fallacy: Why You Can't Mail EDTA Tubes on the Weekend
November 10, 2025
Sepsis vs. SIRS: Can DNA Tell the Difference?
November 3, 2025
Myths and Misconceptions: What cfDNA Cannot Do
October 27, 2025
Beyond Cancer: cfDNA as a 'Severity Meter' in the ICU
October 20, 2025
DeepScan moves to a new office and opens lab in Helsinki
October 12, 2025
When to Say No: Sample Rejection Criteria for the General Practitioner
October 5, 2025
Tissue of Origin: The Holy Grail of Veterinary Liquid Biopsy
September 28, 2025
Lipemia: The Optical Illusion That Breaks Assays
September 21, 2025
Freeze-Thaw Cycles: How to Shatter a Molecule
September 15, 2025
DeepScan welcomes Dr. Zachary Wright as advisor
September 14, 2025
The 4-Hour Rule: The Biology Behind the Clock
September 7, 2025
Nucleosomes vs. cfDNA: Same Biological Event, Different Diagnostic Signal
August 31, 2025
Hemolysis: The 'Red' Flag That Ruins Results
August 24, 2025
cfDNA vs. ctDNA: Finding the Intruder in the House
August 17, 2025
Logistics: Shipping cfDNA Without Ruining the Sample
August 10, 2025
Plasma vs. Serum: Why the Red Top Tube is Forbidden
August 3, 2025
The Double-Spin Protocol: Why One Centrifuge Run is Not Enough
July 27, 2025
Apoptosis, Necrosis, and NETosis: The Three Engines of Cell-Free DNA
July 20, 2025
Fragmentomics: Why Size Matters in Cancer Detection
July 13, 2025
The Tube Wars: K3-EDTA vs. Cell Stabilization Tubes
July 6, 2025
The Speed of Signal: Why cfDNA Half-Life Changes Everything
June 29, 2025
Defining 'Normal': Reference Intervals and Biological Variation in Dogs
June 22, 2025
The Golden Rules: A Clinic SOP for Preanalytical cfDNA Handling
June 15, 2025
cfDNA 101: The Biology of the 'Liquid Biopsy' in Veterinary Medicine
June 3, 2025
DeepScan and Sploot launch CFD test in Colorado
May 22, 2025
DeepScan at ESVONC in Porto
February 15, 2025
DeepScan participating at WVC
February 5, 2025
DeepScan launches with select clinics in Finland
January 25, 2025
DeepScan at VMX
January 20, 2025
DeepScan at WEF in Davos
November 25, 2024
DeepScan raises €2M pre-seed
June 15, 2024
Golden Retrievers Are Living 40% Shorter Lives: Understanding a Breed in Crisis
What is the CFD® Biomarker?
The CFD® biomarker measures circulating cell-free DNA (cfDNA) levels in blood, which correlates with cell destruction in the body. This powerful clinical insight helps veterinarians assess disease severity, detect hidden conditions, and monitor treatment efficacy across acute emergencies and chronic disease management.
The CFD® BiomarkerBuilt on a Foundation of Unparalleled Data and Validation
Latest Manuscript
Circulating cell-free DNA as a canine health biomarker
Veterinary Science · 2025
Download ManuscriptPilot Studies
CFD vs cPLI in Acute Pancreatitis
CFD Monitoring for Phenobarbital-Induced Hepatotoxicity
CFD vs CRP in Neoplasia
CFD in Splenic Disease
CFD Monitoring in Lymphoma Remission
Conference Abstracts
Presented at ESVONC 2025
Minimising Variability of Preanalytical Factors is Key to Successful cfDNA Testing
Circulating Cell Free DNA (cfDNA) Reveals Hidden Illnesses in Dogs
Cell-Free DNA as a Biomarker for ECT and IL-12 GET Treatment Response in Dogs
Led by Experts in Veterinary Oncology and Data Science
Our team combines deep expertise in veterinary oncology, data science, and molecular diagnostics to deliver evidence-based cfDNA solutions that support veterinarians and improve outcomes for dogs.
Katja Kivinen, PhD
Chief Scientific Officer
Gugan Eswaran, PhD
Head of Research and Development
Milja Tikkanen
Head of Laboratory
Emmi Hurskainen
Laboratory Manager
